How to Buy Agios Pharmaceuticals, Inc. (AGIO) Stock

Where to buy AGIO

13 brokers in our matrix offer AGIO. Verify availability and current fees with each broker before trading.

Broker	Commission	Fractional	Extended	Overnight	Options	OTC access
Charles Schwab (thinkorswim)	$0	Schwab Stock Slices, S&P 500 only, ≥ $5/slice, up to 30 at once		~1,130	$0.65	Most (3/5)
E*TRADE (Morgan Stanley)	$0 listed			~20	$0.65	Most (4/5)
Fidelity	$0	Stocks by the Slice, 7,000+ stocks/ETFs, from $1			$0.65	Partial (2+0)
Firstrade	$0	~4,000+ tickers, ≥ $5		~1,200	$0	Most (4/5)
Interactive Brokers	$0 (Lite) / per-share (Pro)			~10,000	per-contract pricing	Full
Merrill Edge	$0				$0.65	Most (3/5)
Moomoo	$0				$0	Limited only
Public.com	$0				rebate model	Limited only
Robinhood	$0	≥ $1 stocks, market cap ≥ $25M		~1,134	$0	None
SoFi Active Investing	$0				$0	Partial (1+2)
tastytrade	$0 stocks				$1.00 open, $0 close (capped at $10 per leg)	Limited only
TradeStation	$0 listed				$0.50 / $0.60	Most (4/5)
Webull	$0				$0	Limited only

24-Hour / Overnight trading

AGIO may be eligible for overnight trading via Charles Schwab (thinkorswim), Interactive Brokers, Robinhood, E*TRADE (Morgan Stanley), Webull, Moomoo, Firstrade. Each broker maintains its own eligibility list — confirm before placing an order.

About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Sector

PHARMACEUTICAL PREPARATIONS

Employees

540

Headquarters

CAMBRIDGE, MA

Listed

2013-07-24

Market cap

$1.69B

Frequently asked

Where can I buy Agios Pharmaceuticals, Inc. (AGIO)?

AGIO is offered by 13 brokers in our matrix, including Charles Schwab (thinkorswim), E*TRADE (Morgan Stanley), Fidelity, Firstrade, Interactive Brokers. Compare commissions, fractional eligibility, and overnight availability in the broker matrix above.

Can I buy AGIO after hours or overnight?

Yes. AGIO is on the 24-hour eligibility list for Charles Schwab (thinkorswim), Interactive Brokers, Robinhood, E*TRADE (Morgan Stanley), and others. Overnight sessions route through ATSs with wider spreads and limit-orders only.

Does Robinhood offer AGIO?

Yes. Robinhood offers AGIO as a regular exchange-listed security.

Does Fidelity offer AGIO?

Yes. Fidelity offers AGIO as a regular exchange-listed security.

Does Webull offer AGIO?

Yes. Webull offers AGIO as a regular exchange-listed security.

Is AGIO optionable?

Yes. AGIO has listed options contracts. Per-contract pricing varies by broker — see the Options column in the matrix.

Is there a tokenized version of AGIO?

Not in our current dataset. The tokenized stock universe (Kraken xStocks, Binance Alpha/Ondo, Robinhood EU, Hyperliquid HIP-3) is expanding quickly — we refresh quarterly.

Can I buy a fractional share of AGIO?

Yes. Multiple brokers in the matrix support fractional shares for AGIO — see the Fractional column above for per-broker eligibility and minimums.